According to a new research report titled “ Emerging Pharmaceutical Markets Globally”, by RNCOS, China has witnessed rapidly increasing growth in the pharmaceutical markets, owing to emergence of a strong economic nation in the world. The growth of the industry will be driven by the high population base, healthcare spending, and high prevalence of chronic diseases. The pharmaceutical market in China is likely to reach US$ 87.2 Billion by 2014, growing at an impressive CAGR of around 20% during 2011-2014.
The pharmaceutical market in the E7 countries has continued to witness rapid growth over the last few years, owing to their increasing healthcare spending, disease profile, and favorable government initiatives. According to latest report by RNCOS, fast growth in population and increasing income levels will still be the prevailing factors for the high growth in the coming years. Also, increasing penetration of health insurance has constructed a suitable platform for stronger pharmaceutical market growth.
The report, “Emerging Pharmaceutical Markets Globally”, provides an in-depth research and rational analysis of the current status and future scenario of the pharmaceutical market in E7 countries. It facilitates the future forecasts of each country’s pharmaceutical market during 2011-2014. The report also provides current data on the branded and generic drugs, imports and exports, key players, and disease profile of each country. Additionally, analysis of the healthcare spending has been included in the report to provide a balanced outlook on the potentials of the E7 pharmaceutical industry.
Some of our Related Reports are as follows:
- Booming Clinical Trials Market in India
- Global Obesity Drug Market Analysis
- Global Telemedicine Market Analysis
- Clinical Trials Market in Russia
- Indian Pharma Sector Forecast 2014
|
